Molina Healthcare (NYSE:MOH) Lowered to “Underperform” at Bank of America

Molina Healthcare (NYSE:MOH) was downgraded by Bank of America from a “neutral” rating to an “underperform” rating in a report released on Thursday, MarketBeat.com reports. They currently have a $439.00 target price on the stock. Bank of America‘s price target would indicate a potential upside of 4.90% from the stock’s previous close.

A number of other research firms have also recently weighed in on MOH. Barclays started coverage on shares of Molina Healthcare in a research report on Wednesday, March 6th. They issued an “equal weight” rating and a $437.00 price objective for the company. StockNews.com cut shares of Molina Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Thursday, February 8th. UBS Group increased their price target on shares of Molina Healthcare from $350.00 to $380.00 and gave the stock a “neutral” rating in a research report on Thursday, December 21st. Cantor Fitzgerald increased their price target on shares of Molina Healthcare from $374.00 to $406.00 and gave the stock an “overweight” rating in a research report on Friday, February 9th. Finally, Wells Fargo & Company increased their price target on shares of Molina Healthcare from $420.00 to $440.00 and gave the stock an “equal weight” rating in a research report on Wednesday, March 20th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and five have issued a buy rating to the company’s stock. Based on data from MarketBeat, Molina Healthcare has a consensus rating of “Hold” and an average target price of $395.82.

Molina Healthcare Stock Up 0.0 %

Shares of NYSE MOH opened at $418.51 on Thursday. Molina Healthcare has a 12-month low of $263.20 and a 12-month high of $423.92. The company has a market cap of $24.52 billion, a P/E ratio of 22.28, a P/E/G ratio of 1.17 and a beta of 0.47. The company has a current ratio of 1.54, a quick ratio of 1.54 and a debt-to-equity ratio of 0.57. The stock has a fifty day moving average price of $388.98 and a 200 day moving average price of $365.51.

Molina Healthcare (NYSE:MOH) last posted its quarterly earnings data on Wednesday, February 7th. The company reported $4.38 earnings per share for the quarter, beating analysts’ consensus estimates of $4.31 by $0.07. The company had revenue of $9.05 billion during the quarter, compared to analysts’ expectations of $8.35 billion. Molina Healthcare had a net margin of 3.20% and a return on equity of 32.34%. The firm’s revenue for the quarter was up 10.0% on a year-over-year basis. During the same period in the prior year, the company posted $4.10 EPS. Research analysts anticipate that Molina Healthcare will post 23.62 EPS for the current fiscal year.

Insider Buying and Selling at Molina Healthcare

In other Molina Healthcare news, CFO Mark Lowell Keim sold 15,000 shares of the firm’s stock in a transaction that occurred on Monday, February 12th. The shares were sold at an average price of $386.56, for a total value of $5,798,400.00. Following the sale, the chief financial officer now owns 36,531 shares in the company, valued at $14,121,423.36. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In related news, CFO Mark Lowell Keim sold 15,000 shares of the firm’s stock in a transaction that occurred on Monday, February 12th. The shares were sold at an average price of $386.56, for a total transaction of $5,798,400.00. Following the transaction, the chief financial officer now owns 36,531 shares in the company, valued at $14,121,423.36. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Richard M. Schapiro sold 711 shares of the firm’s stock in a transaction that occurred on Monday, February 12th. The shares were sold at an average price of $384.06, for a total transaction of $273,066.66. Following the transaction, the director now owns 12,207 shares in the company, valued at approximately $4,688,220.42. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 16,711 shares of company stock worth $6,472,517. 1.10% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the stock. Annis Gardner Whiting Capital Advisors LLC bought a new stake in Molina Healthcare during the third quarter worth approximately $30,000. McIlrath & Eck LLC bought a new stake in Molina Healthcare during the fourth quarter worth approximately $34,000. Coppell Advisory Solutions Corp. bought a new stake in Molina Healthcare during the fourth quarter worth approximately $34,000. ST Germain D J Co. Inc. bought a new stake in Molina Healthcare during the second quarter worth approximately $33,000. Finally, VisionPoint Advisory Group LLC boosted its holdings in Molina Healthcare by 105.6% during the third quarter. VisionPoint Advisory Group LLC now owns 111 shares of the company’s stock worth $36,000 after buying an additional 57 shares in the last quarter. Institutional investors and hedge funds own 98.50% of the company’s stock.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.